Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y V Mirolyubova

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Molekuliarnaia Biologiia|February 10, 2021
[CASC5</I> Gene Expression Changes Correlate with Targeted Mutations in Leukemia]K V Bogdanov, O V Merzlikina, Y V Mirolyubova, et al.
Biomeditsinskaia Khimiia|December 19, 2017
[Donor chimerism and minimal residual disease monitoring in leukemia patients after allo-HSCT]K V Bogdanov, D V Motorin, T S Nikulina, et al.
Acta Naturae|August 7, 2025
The Emergence of a Novel Insertional Mutation in the BCR::ABL/p210 Oncogene in B-Cell Acute Lymphoblastic Leukemia (B-ALL) Correlates with the Development of Resistance to Several Tyrosine Kinase InhibitorsK V Bogdanov, E S Kudryavtseva, Y N Lobacheva, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Molekuliarnaia Biologiia|February 10, 2021
[CASC5</I> Gene Expression Changes Correlate with Targeted Mutations in Leukemia]K V Bogdanov, O V Merzlikina, Y V Mirolyubova, et al.
Biomeditsinskaia Khimiia|December 19, 2017
[Donor chimerism and minimal residual disease monitoring in leukemia patients after allo-HSCT]K V Bogdanov, D V Motorin, T S Nikulina, et al.
Acta Naturae|August 7, 2025
The Emergence of a Novel Insertional Mutation in the BCR::ABL/p210 Oncogene in B-Cell Acute Lymphoblastic Leukemia (B-ALL) Correlates with the Development of Resistance to Several Tyrosine Kinase InhibitorsK V Bogdanov, E S Kudryavtseva, Y N Lobacheva, et al.
Pageof 1